Australia appears to be gain access to innovative treatment for weight issues: Retatrutide. This dual compound – acting on both GLP-1 and GIP receptors – shows promising outcomes in international trials, pointing to meaningful reductions in BMI. While availability hasn't occurred with TGA, several individuals battling obesity are hoping for Ret